Impact of Induction Immunosuppressants on T Lymphocyte Subsets after Kidney Transplantation: A Prospective Observational Study with Focus on Anti-Thymocyte Globulin and Basiliximab Induction Therapies
Induction immunosuppressive therapy for kidney transplant recipients (KTRs) primarily includes interleukin-2 receptor antagonists, such as basiliximab (BXM) or lymphocyte-depleting agents, and anti-thymocyte globulin (ATG). This study aimed to investigate their effects on T cell dynamics during the...
Main Authors: | Hyung Duk Kim, Hyunjoo Bae, Sojeong Yun, Hanbi Lee, Sang Hun Eum, Chul Woo Yang, Eun-Jee Oh, Byung Ha Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/18/14288 |
Similar Items
-
Outcome Comparison between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation
by: Sang Jin Kim, et al.
Published: (2020-05-01) -
Basiliximab vs. Antithymocyte Globulin as Initial Induction Therapy for Lung Transplantation: A National Two Years Review
by: Bruno Mendes, et al.
Published: (2022-08-01) -
Outcomes in live renal allograft transplants with different modalities of induction: A hospital-based retrospective study in Odisha
by: Datteswar Hota, et al.
Published: (2022-01-01) -
Cutaneous Finding in Anti Thymocyte Globulin Induced Serum Sickness
by: Seyed Hesamedin Nabavizadeh, et al.
Published: (2006-03-01) -
Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usage
by: Paolo Malvezzi, et al.
Published: (2015-10-01)